Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P23193 (
transcription elongation factor
)
739
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
YEATS domain containing 4
(
YEATS4
) is usually amplified and functions as an oncogene in several malignancies, such as colorectum, ovarian, breast and lung. However, the biological role of
YEATS4
in hepatocellular carcinoma (HCC) has not yet been discussed. Herein, we found that
YEATS4
was significantly upregulated in HCC compared to para-cancerous tissues, and was associated with poor prognosis, large tumor size, poor differentiation and distant metastasis. In addition,
YEATS4
promoted HCC cell proliferation and colony formation by binding to and increasing the transcriptional activity of the
TCEA1
promoter. Concurrently, upregulation of
TCEA1
increased the stability of the DDX3 protein, a member of the DEAD box RNA helicase family, and augmented the proliferative and colony forming ability of HCC cells. Furthermore,
YEATS4
accelerated tumor growth
in vivo
in a xenograft HCC model. Taken together, our study provides evidence for the first time on the potential role of the
YEATS4
/
TCEA1
/DDX3 axis in regulating HCC progression, and presents
YEATS4
as a promising therapeutic target and prognosis maker for HCC.
...
PMID:Abnormal expression of YEATS4 associates with poor prognosis and promotes cell proliferation of hepatic carcinoma cell by regulation the TCEA1/DDX3 axis. 3041 57